Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaleh Barar

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Bioimpacts : BI|October 13, 2015
Bioimpacts of nanoparticle size: why it matters?Jaleh Barar
Bioimpacts : BI|August 15, 2020
COVID-19 clinical implications: the significance of nanomedicineJaleh Barar
Bioimpacts : BI|May 17, 2013
Targeting tumor microenvironment: the key role of immune systemJaleh Barar
Bioimpacts : BI|July 21, 2015
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignanciesJaleh Barar, Yadollah Omidi
Bioimpacts : BI|May 3, 2014
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancerJaleh Barar, Yadollah Omidi
Bioimpacts : BI|May 17, 2013
Impacts of nanomedicines in ocular pharmacotherapyAilar Nakhlband, Jaleh Barar
Bioimpacts : BI|July 24, 2013
Targeted Gene Therapy of Cancer: Second Amendment toward Holistic TherapyJaleh Barar, Yadollah Omidi
Bioimpacts : BI|October 29, 2013
Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goalsJaleh Barar, Yadollah Omidi
Bioimpacts : BI|June 12, 2026
Pharmacists in modern primary care and management of diseases: an evidence-based perspective on emerging technologiesJaleh Barar, Yadollah Omidi
Bioimpacts : BI|August 3, 2023
Erratum: Erratum to: Impacts of Nanomedicines in Ocular PharmacotherapyAilar Nakhlband, Jaleh Barar
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Bioimpacts : BI|October 13, 2015
Bioimpacts of nanoparticle size: why it matters?Jaleh Barar
Bioimpacts : BI|August 15, 2020
COVID-19 clinical implications: the significance of nanomedicineJaleh Barar
Bioimpacts : BI|May 17, 2013
Targeting tumor microenvironment: the key role of immune systemJaleh Barar
Bioimpacts : BI|July 21, 2015
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignanciesJaleh Barar, Yadollah Omidi
Bioimpacts : BI|May 3, 2014
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancerJaleh Barar, Yadollah Omidi
Bioimpacts : BI|May 17, 2013
Impacts of nanomedicines in ocular pharmacotherapyAilar Nakhlband, Jaleh Barar
Bioimpacts : BI|July 24, 2013
Targeted Gene Therapy of Cancer: Second Amendment toward Holistic TherapyJaleh Barar, Yadollah Omidi
Bioimpacts : BI|October 29, 2013
Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goalsJaleh Barar, Yadollah Omidi
Bioimpacts : BI|June 12, 2026
Pharmacists in modern primary care and management of diseases: an evidence-based perspective on emerging technologiesJaleh Barar, Yadollah Omidi
Bioimpacts : BI|August 3, 2023
Erratum: Erratum to: Impacts of Nanomedicines in Ocular PharmacotherapyAilar Nakhlband, Jaleh Barar
Pageof 17